Skip to main content
FinSpry Logo
FinSpry
GRCE logo
GRCE
(NASDAQ)
Grace Therapeutics, Inc.
$2.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Grace Therapeutics (GRCE) Stock Price & Financial Analysis

Grace Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.16 - $2.34
52-Week High$5.18
52-Week Low$1.79
Open$2.31
Volume406.72K
Average Volume (3M)365.50K
Market Cap39.12M
Shares Outstanding16.93M
Price to Book (P/B)0.60
EV/EBITDA-1.82
50-Day MA$2.88
200-Day MA$3.32
52-Week Change-19.30%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Grace Therapeutics

What is the current stock price for GRCE?

As of the latest trading session, GRCE stock trades at $2.20. The 52-week range is $1.79–$5.18, with a day range of $2.16–$2.34.

What is the P/E ratio for GRCE?

The P/E ratio (Price-to-Earnings) for GRCE is shown in the Key Statistics section. This valuation metric helps compare Grace Therapeutics, Inc. to industry peers.

Does GRCE pay dividends?

Grace Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GRCE?

Based on 1 analyst, the consensus for GRCE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of GRCE?

Grace Therapeutics's market capitalization is $37.3M, classifying it as a micro-cap company. Grace Therapeutics operates in the Healthcare sector within the Biotechnology industry.